Article metrics

Download PDFPDF

Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol

 

Online download statistics by month:

Online download statistics by month: March 2019 to May 2021

AbstractFullPdf
Mar 2019570551187
Apr 2019611593278
May 201923421083
Jun 201917315567
Jul 201914413263
Aug 201911310955
Sep 201910910547
Oct 20191099439
Nov 201911910649
Dec 2019888039
Jan 202010410143
Feb 202012811458
Mar 202012712245
Apr 202016715770
May 2020978574
Jun 202015313990
Jul 202012911071
Aug 20201079551
Sep 202014212591
Oct 202016714394
Nov 20201139863
Dec 202014313973
Jan 20211209743
Feb 20211049059
Mar 202120418179
Apr 202112710653
May 2021292716
Total443140641980